Studies

CellWell record HH-76330

CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy

Wen M; Zheng R; Zhang H; Goldberg SY; Jian Z; Gao Y; Cheng R; Wen L; Zhao Y; Kenderian SS; Shang P

Journal of neuroinflammation ยท 2026

In plain language

A review of CAR T cell therapy for antibody-driven neurological autoimmune disorders classifies approaches by target antigen and reports early clinical progress alongside safety concerns including neurotoxicity.

Evidence
Emerging

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-76330

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.